Antios Therapeutics

📍 Atlanta, United States🗓 Founded 2018👥 5 employees💰 Last funded Dec 2018
Biotechnology Research🌐 antiostherapeutics.com
Website LinkedIn
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its lead oral drug candidate for a potentially curative treatment of HBV infections.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Antios Therapeutics?
Antios Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Antios Therapeutics last raise funding?
The most recent investment in Antios Therapeutics recorded on gritt.io was in December 2018.
When was Antios Therapeutics founded?
Antios Therapeutics was founded in 2018.
What industry is Antios Therapeutics in?
Antios Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Antios Therapeutics based?
Antios Therapeutics is headquartered in Atlanta, United States.